Fingerprint
Dive into the research topics where Abhishek Maiti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase I, single-arm, open-label, dose-escalation, multicenter study of SAR445419, an off-the-shelf, ex vivo expanded allogeneic natural killer cell product, in participants with relapsed or refractory acute myeloid leukemia
Konopleva, M., Bhatt, V. R., Mantzaris, I., Maiti, A., Gundabolu, K., Schafer, J., Jensen, K., Saleem, R., Li, Y., Drewniak, A., Bay, P., Huh, W., Yildirim, O., Abbadessa, G., Cooley, S. & Daver, N., May 2026, In: Cancer Immunology, Immunotherapy. 75, 5, 143.Research output: Contribution to journal › Article › peer-review
Open Access -
Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia
Azevedo, R. S., Braish, J., Gener-Ricos, G., Tang, G., Sasaki, K., Montalban-Bravo, G., Jabbour, E., Ohanian, M., Yilmaz, M., Haddad, F. G., Chien, K., Ishizawa, J., Short, N. J., Maiti, A., Swaminathan, M., Kantarjian, H., Borthakur, G. & Kadia, T. M., 2026, In: Leukemia and Lymphoma. 67, 1, p. 220-224 5 p.Research output: Contribution to journal › Letter › peer-review
1 Link opens in a new tab Scopus citations -
Clinical, genetic, and familial features of POT1 tumor predisposition syndrome
DiNardo, C. D., Croden, J., Abdel-Salam, H. M., Kadia, T., Molica, M., Bazinet, A., Bose, P., Maiti, A., Haddad, F. G., Burger, J. A., Kantarjian, H. M., Wierda, W., Jain, N. & Ferrajoli, A., Feb 15 2026, In: Cancer. 132, 4, e70315.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia (Leukemia, (2025), 39, 4, (854-863), 10.1038/s41375-025-02531-8)
DiNardo, C. D., Jen, W. Y., Takahashi, K., Kadia, T. M., Loghavi, S., Daver, N. G., Xiao, L., Reville, P. K., Issa, G. C., Short, N. J., Sasaki, K., Wang, S. A., Mullin, J. K., Pierce, S., Bradley, C., Borthakur, G., Maiti, A., Alvarado, Y., Pemmaraju, N. & Ferrajoli, A. & 18 others, , Jan 2026, In: Leukemia. 40, 1, p. 262 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Evaluating the Impact of Fewer Frontline Intensive Chemotherapy Plus Venetoclax Consolidation Cycles on Outcomes in AML
Marvin-Peek, J., Kantarjian, H., Jen, W. Y., Daver, N., Short, N., Borthakur, G., Bazinet, A., Maiti, A., Abbas, H., Yilmaz, M., Issa, G., Macfarland, M., Alvarado, Y., Garcia-Manero, G., Alousi, A., Popat, U., Shpall, E., Ravandi, F., DiNardo, C. & Kadia, T. M., Apr 2026, In: American journal of hematology. 101, 4, p. 917-922 6 p.Research output: Contribution to journal › Letter › peer-review